Wolverine Stack Results Timeline
What the standard Wolverine Stack research protocol looks like phase by phase, over a typical 8–12 weeks cycle. This is the escalation schedule from our full dosing protocol, presented as a timeline rather than a table.
Quick Facts
FREQUENCYBPC-157 daily / TB-500 twice weekly
CYCLE LENGTH8–12 weeks
DOSE RANGEBPC-157: 400–600 mcg/day · TB-500: 2–2.5 mg twice weekly
ROUTESubcutaneous injection
Phase-by-Phase Timeline
Loading / Titration
Weeks 1–2 (BPC-157)
Target dose: 400 mcg
Escalation
Weeks 3–8+ (BPC-157)
Target dose: 600 mcg
Escalation
Weeks 1–2 (TB-500)
Target dose: 2,000 mcg (2x/wk)
Maintenance
Weeks 3–8+ (TB-500)
Target dose: 2,500 mcg (2x/wk)
Reported in Research
- ✓Run both peptides concurrently for 8–12 weeks.
- ✓BPC-157 may be extended beyond 12 weeks if needed; TB-500 is typically cycled.
This timeline reflects the structure of the standard Wolverine Stack research protocol documented on this site — it is not a guarantee of individual outcomes, and timelines vary between research subjects. All products sold by JA Performance Peptides are intended strictly for laboratory research purposes and are not approved for human consumption, veterinary use, or therapeutic application. Not for human use.